Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs2975748 | chr2:241518989 | A/G | 1.73E-9 | 490 | 25.37 | 31.93 | 30.2 | KM Plot |
PRAD | rs2975794 | chr2:241515813 | C/T | 1.73E-9 | 490 | 25.37 | 31.93 | 30.2 | KM Plot |
PRAD | rs2993972 | chr9:97368387 | A/G | 1.61E-5 | 486 | 17.07 | 25.68 | 32.43 | KM Plot |
PRAD | rs3018948 | chr8:104016753 | A/G | 4.42E-12 | 479 | 31.07 | 29.08 | 4.87 | KM Plot |
PRAD | rs3031405 | chr2:178790795 | TAAAG/T | 4.13E-5 | 494 | 30.77 | 31.93 | 20.48 | KM Plot |
PRAD | rs3066513 | chr1:93603183 | C/CAT | 1.38E-8 | 488 | 9.17 | 27.13 | 31.37 | KM Plot |
PRAD | rs3087457 | chr1:93811917 | C/T | 3.67E-6 | 493 | 31.3 | 28.4 | 18.97 | KM Plot |
PRAD | rs3088324 | chr1:202694784 | A/G | 3.39E-5 | 494 | 24.2 | 28.23 | 31.12 | KM Plot |
PRAD | rs3103589 | chr5:171532333 | T/C | 1.69E-7 | 492 | 30.93 | 32 | 13.17 | KM Plot |
PRAD | rs3103590 | chr5:171532277 | C/T | 1.63E-7 | 494 | 30.93 | 32 | 13.17 | KM Plot |
PRAD | rs3103591 | chr5:171532229 | G/A | 1.66E-7 | 493 | 30.87 | 32 | 13.17 | KM Plot |
PRAD | rs3103592 | chr5:171531992 | A/G | 1.66E-7 | 493 | 30.87 | 32 | 13.17 | KM Plot |
PRAD | rs3103594 | chr5:171531899 | G/A | 1.66E-7 | 493 | 30.87 | 32 | 13.17 | KM Plot |
PRAD | rs3111483 | chr5:171532497 | C/T | 1.63E-7 | 494 | 30.93 | 32 | 13.17 | KM Plot |
PRAD | rs3111484 | chr5:171532397 | C/T | 1.63E-7 | 494 | 30.93 | 32 | 13.17 | KM Plot |